Matches in SemOpenAlex for { <https://semopenalex.org/work/W4360951491> ?p ?o ?g. }
- W4360951491 abstract "Abstract Background Fibroblast growth factors (FGFs) and their receptors (FGFRs) play a crucial role in cell fate and angiogenesis, with dysregulation of the signaling axis driving tumorigenesis. Therefore, many studies have targeted FGF/FGFR signaling for cancer therapy and several FGFR inhibitors have promising results in different tumors but treatment efficiency may still be improved. The clinical use of immune checkpoint blockade (ICB) has resulted in sustained remission for patients. Main Although there is limited data linking FGFR inhibitors and immunotherapy, preclinical research suggest that FGF/FGFR signaling is involved in regulating the tumor microenvironment (TME) including immune cells, vasculogenesis, and epithelial-mesenchymal transition (EMT). This raises the possibility that ICB in combination with FGFR-tyrosine kinase inhibitors (FGFR-TKIs) may be feasible for treatment option for patients with dysregulated FGF/FGFR signaling. Conclusion Here, we review the role of FGF/FGFR signaling in TME regulation and the potential mechanisms of FGFR-TKI in combination with ICB. In addition, we review clinical data surrounding ICB alone or in combination with FGFR-TKI for the treatment of FGFR-dysregulated tumors, highlighting that FGFR inhibitors may sensitize the response to ICB by impacting various stages of the “cancer-immune cycle”." @default.
- W4360951491 created "2023-03-26" @default.
- W4360951491 creator A5001948075 @default.
- W4360951491 creator A5018146732 @default.
- W4360951491 creator A5020966645 @default.
- W4360951491 creator A5025035488 @default.
- W4360951491 creator A5027475930 @default.
- W4360951491 creator A5027937292 @default.
- W4360951491 creator A5033777220 @default.
- W4360951491 creator A5042829870 @default.
- W4360951491 creator A5045673283 @default.
- W4360951491 creator A5048218804 @default.
- W4360951491 creator A5056099873 @default.
- W4360951491 creator A5058311447 @default.
- W4360951491 creator A5059064183 @default.
- W4360951491 creator A5059456733 @default.
- W4360951491 creator A5064234915 @default.
- W4360951491 creator A5065119436 @default.
- W4360951491 creator A5068044246 @default.
- W4360951491 date "2023-03-25" @default.
- W4360951491 modified "2023-10-16" @default.
- W4360951491 title "Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment" @default.
- W4360951491 cites W1480357432 @default.
- W4360951491 cites W1493344427 @default.
- W4360951491 cites W1497172665 @default.
- W4360951491 cites W1524819089 @default.
- W4360951491 cites W1534863661 @default.
- W4360951491 cites W1678482413 @default.
- W4360951491 cites W1811586967 @default.
- W4360951491 cites W1894751757 @default.
- W4360951491 cites W1927075449 @default.
- W4360951491 cites W1956285448 @default.
- W4360951491 cites W1960850967 @default.
- W4360951491 cites W1967060514 @default.
- W4360951491 cites W1971620413 @default.
- W4360951491 cites W1973037312 @default.
- W4360951491 cites W1976651544 @default.
- W4360951491 cites W1977799997 @default.
- W4360951491 cites W1988476050 @default.
- W4360951491 cites W1994993231 @default.
- W4360951491 cites W1996863944 @default.
- W4360951491 cites W1997081071 @default.
- W4360951491 cites W1997117548 @default.
- W4360951491 cites W1998518732 @default.
- W4360951491 cites W2002889122 @default.
- W4360951491 cites W2004630197 @default.
- W4360951491 cites W2007210106 @default.
- W4360951491 cites W2012642473 @default.
- W4360951491 cites W2025630797 @default.
- W4360951491 cites W2025870139 @default.
- W4360951491 cites W2027239974 @default.
- W4360951491 cites W2031960993 @default.
- W4360951491 cites W2033073864 @default.
- W4360951491 cites W2033278321 @default.
- W4360951491 cites W2038781914 @default.
- W4360951491 cites W2042259396 @default.
- W4360951491 cites W2046172352 @default.
- W4360951491 cites W2046692530 @default.
- W4360951491 cites W2047265596 @default.
- W4360951491 cites W2049491375 @default.
- W4360951491 cites W2049553585 @default.
- W4360951491 cites W2054195724 @default.
- W4360951491 cites W2056983875 @default.
- W4360951491 cites W2057232050 @default.
- W4360951491 cites W2060070314 @default.
- W4360951491 cites W2060320549 @default.
- W4360951491 cites W2067632426 @default.
- W4360951491 cites W2068708251 @default.
- W4360951491 cites W2071062791 @default.
- W4360951491 cites W2072853625 @default.
- W4360951491 cites W2074536446 @default.
- W4360951491 cites W2078054478 @default.
- W4360951491 cites W2080860848 @default.
- W4360951491 cites W2086846496 @default.
- W4360951491 cites W2087913184 @default.
- W4360951491 cites W2095916019 @default.
- W4360951491 cites W2096322385 @default.
- W4360951491 cites W2097995306 @default.
- W4360951491 cites W2098308961 @default.
- W4360951491 cites W2098637021 @default.
- W4360951491 cites W2103898770 @default.
- W4360951491 cites W2106116393 @default.
- W4360951491 cites W2109092551 @default.
- W4360951491 cites W2109134893 @default.
- W4360951491 cites W2111564953 @default.
- W4360951491 cites W2112278221 @default.
- W4360951491 cites W2114703597 @default.
- W4360951491 cites W2116215301 @default.
- W4360951491 cites W2117692326 @default.
- W4360951491 cites W2120426523 @default.
- W4360951491 cites W2120687087 @default.
- W4360951491 cites W2122135343 @default.
- W4360951491 cites W2122403898 @default.
- W4360951491 cites W2124208429 @default.
- W4360951491 cites W2128565827 @default.
- W4360951491 cites W2130275173 @default.
- W4360951491 cites W2130473166 @default.
- W4360951491 cites W2131783235 @default.
- W4360951491 cites W2136799969 @default.
- W4360951491 cites W2136964874 @default.